BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19164447)

  • 21. Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate.
    Desai KV; Michalowska AM; Kondaiah P; Ward JM; Shih JH; Green JE
    Mol Endocrinol; 2004 Dec; 18(12):2895-907. PubMed ID: 15358834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.
    Poluri RTK; Paquette V; Allain ÉP; Lafront C; Joly-Beauparlant C; Weidmann C; Droit A; Guillemette C; Pelletier M; Audet-Walsh É
    Endocr Relat Cancer; 2021 Apr; 28(4):257-271. PubMed ID: 33690159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of transcription factor co-regulators that drive prostate cancer progression.
    Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ
    Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms.
    Flores-Ramírez I; Rivas-Torres MÁ; Rodríguez-Dorantes M; Gutiérrez-Sagal R; Baranda-Avila N; Langley E
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105858. PubMed ID: 33647521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells.
    Rahman MM; Miyamoto H; Takatera H; Yeh S; Altuwaijri S; Chang C
    J Biol Chem; 2003 May; 278(22):19619-26. PubMed ID: 12649293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.
    Levina E; Ji H; Chen M; Baig M; Oliver D; Ohouo P; Lim CU; Schools G; Carmack S; Ding Y; Broude EV; Roninson IB; Buttyan R; Shtutman M
    Oncotarget; 2015 May; 6(15):13088-104. PubMed ID: 26036626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
    Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ
    Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.
    Yang Y; Jia D; Kim H; Abd Elmageed ZY; Datta A; Davis R; Srivastav S; Moroz K; Crawford BE; Moparty K; Thomas R; Hudson RS; Ambs S; Abdel-Mageed AB
    Clin Cancer Res; 2016 Apr; 22(7):1744-56. PubMed ID: 26553749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
    Wang G; Wang Y; Feng W; Wang X; Yang JY; Zhao Y; Wang Y; Liu Y
    BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S22. PubMed ID: 18831788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.
    Heemers HV; Tindall DJ
    Endocr Rev; 2007 Dec; 28(7):778-808. PubMed ID: 17940184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.
    Shaw GL; Whitaker H; Corcoran M; Dunning MJ; Luxton H; Kay J; Massie CE; Miller JL; Lamb AD; Ross-Adams H; Russell R; Nelson AW; Eldridge MD; Lynch AG; Ramos-Montoya A; Mills IG; Taylor AE; Arlt W; Shah N; Warren AY; Neal DE
    Eur Urol; 2016 Aug; 70(2):214-8. PubMed ID: 26572708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
    Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorbitol dehydrogenase expression is regulated by androgens in the human prostate.
    Szabó Z; Hämäläinen J; Loikkanen I; Moilanen AM; Hirvikoski P; Väisänen T; Paavonen TK; Vaarala MH
    Oncol Rep; 2010 May; 23(5):1233-9. PubMed ID: 20372835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.